4//SEC Filing
Kearns Evan 4
Accession 0000899243-21-018362
CIK 0001622229other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:37 PM ET
Size
5.6 KB
Accession
0000899243-21-018362
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-03+260,000→ 260,000 totalExercise: $8.93Exp: 2031-05-03→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over a four year period as follows: 1/4th of the option shall vest one year after the vesting start date; then 1/48th of the option shall vest monthly over the remaining three year period.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001745285
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:37 PM ET
- Size
- 5.6 KB